Concepts (179)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muromegalovirus | 8 | 2016 | 11 | 1.610 |
Why?
|
| Herpesviridae Infections | 4 | 2016 | 181 | 0.910 |
Why?
|
| Clinical Laboratory Techniques | 2 | 2021 | 194 | 0.830 |
Why?
|
| Influenza B virus | 2 | 2023 | 97 | 0.770 |
Why?
|
| Antigens, Viral | 2 | 2021 | 495 | 0.730 |
Why?
|
| Influenza, Human | 3 | 2024 | 761 | 0.720 |
Why?
|
| Disease Notification | 1 | 2020 | 10 | 0.710 |
Why?
|
| False Positive Reactions | 1 | 2021 | 374 | 0.700 |
Why?
|
| Influenza A virus | 1 | 2021 | 166 | 0.680 |
Why?
|
| Cytomegalovirus Infections | 4 | 2014 | 491 | 0.640 |
Why?
|
| Encephalitis | 3 | 2014 | 149 | 0.610 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2014 | 1656 | 0.590 |
Why?
|
| Microglia | 3 | 2014 | 180 | 0.550 |
Why?
|
| Vaccines | 1 | 2021 | 373 | 0.540 |
Why?
|
| Respiratory Tract Infections | 1 | 2020 | 405 | 0.520 |
Why?
|
| Pandemics | 3 | 2021 | 1608 | 0.490 |
Why?
|
| B-Lymphocytes, Regulatory | 1 | 2014 | 23 | 0.480 |
Why?
|
| Interleukin-10 | 4 | 2014 | 479 | 0.480 |
Why?
|
| Brain | 7 | 2016 | 4202 | 0.450 |
Why?
|
| Murine Acquired Immunodeficiency Syndrome | 1 | 2013 | 1 | 0.450 |
Why?
|
| Central Nervous System Viral Diseases | 1 | 2013 | 13 | 0.440 |
Why?
|
| Herpes Simplex | 1 | 2013 | 101 | 0.410 |
Why?
|
| Seasons | 3 | 2024 | 333 | 0.410 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2013 | 189 | 0.410 |
Why?
|
| Immunity, Humoral | 1 | 2012 | 87 | 0.380 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2013 | 1044 | 0.370 |
Why?
|
| Brucella melitensis | 2 | 2007 | 8 | 0.360 |
Why?
|
| Brucellosis | 2 | 2007 | 20 | 0.350 |
Why?
|
| Encephalitis, Viral | 1 | 2010 | 28 | 0.350 |
Why?
|
| Virus Activation | 1 | 2012 | 240 | 0.350 |
Why?
|
| Neutrophil Infiltration | 1 | 2010 | 105 | 0.350 |
Why?
|
| Central Nervous System | 1 | 2012 | 450 | 0.330 |
Why?
|
| Immunologic Memory | 1 | 2011 | 376 | 0.330 |
Why?
|
| Neural Stem Cells | 1 | 2011 | 183 | 0.330 |
Why?
|
| Interferon-gamma | 3 | 2014 | 1169 | 0.320 |
Why?
|
| Influenza Vaccines | 2 | 2024 | 496 | 0.310 |
Why?
|
| Neurogenesis | 1 | 2011 | 241 | 0.310 |
Why?
|
| Gram-Negative Anaerobic Bacteria | 1 | 2008 | 1 | 0.310 |
Why?
|
| Hemagglutination | 1 | 2008 | 9 | 0.310 |
Why?
|
| Siderophores | 1 | 2008 | 13 | 0.300 |
Why?
|
| Enzymes | 1 | 2008 | 69 | 0.290 |
Why?
|
| Bacterial Adhesion | 1 | 2008 | 146 | 0.280 |
Why?
|
| Skin Diseases, Bacterial | 1 | 2007 | 42 | 0.280 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 2 | 2024 | 136 | 0.270 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2008 | 170 | 0.270 |
Why?
|
| Texas | 3 | 2021 | 6446 | 0.250 |
Why?
|
| Escherichia coli Infections | 1 | 2008 | 262 | 0.250 |
Why?
|
| Mice, Inbred BALB C | 5 | 2014 | 2419 | 0.240 |
Why?
|
| DNA, Bacterial | 1 | 2007 | 604 | 0.240 |
Why?
|
| Prevalence | 3 | 2021 | 3395 | 0.220 |
Why?
|
| Urinary Tract Infections | 1 | 2008 | 347 | 0.210 |
Why?
|
| Mice, Knockout | 5 | 2014 | 5692 | 0.210 |
Why?
|
| Escherichia coli | 2 | 2011 | 1286 | 0.210 |
Why?
|
| Polymerase Chain Reaction | 3 | 2011 | 3464 | 0.200 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2024 | 213 | 0.200 |
Why?
|
| Bacterial Proteins | 1 | 2008 | 1088 | 0.190 |
Why?
|
| Antibodies, Viral | 3 | 2020 | 1218 | 0.190 |
Why?
|
| Device Approval | 1 | 2021 | 18 | 0.190 |
Why?
|
| Outpatients | 1 | 2024 | 463 | 0.180 |
Why?
|
| NIH 3T3 Cells | 2 | 2012 | 254 | 0.180 |
Why?
|
| Serologic Tests | 1 | 2020 | 139 | 0.180 |
Why?
|
| Epidemiological Monitoring | 1 | 2020 | 84 | 0.170 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2022 | 386 | 0.170 |
Why?
|
| Emergencies | 1 | 2021 | 224 | 0.160 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2020 | 1503 | 0.160 |
Why?
|
| Mice | 9 | 2016 | 35421 | 0.160 |
Why?
|
| B-Lymphocytes | 2 | 2016 | 1420 | 0.150 |
Why?
|
| Animals | 12 | 2016 | 61357 | 0.140 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 1195 | 0.130 |
Why?
|
| Vaccination | 3 | 2024 | 1113 | 0.130 |
Why?
|
| Betacoronavirus | 1 | 2020 | 514 | 0.130 |
Why?
|
| Sensitivity and Specificity | 2 | 2021 | 5157 | 0.120 |
Why?
|
| Neuroglia | 1 | 2016 | 251 | 0.110 |
Why?
|
| Animals, Newborn | 3 | 2016 | 1288 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 623 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 701 | 0.100 |
Why?
|
| Adoptive Transfer | 1 | 2014 | 431 | 0.100 |
Why?
|
| Virus Latency | 1 | 2012 | 80 | 0.100 |
Why?
|
| Genes, MHC Class II | 1 | 2011 | 71 | 0.100 |
Why?
|
| HIV Seropositivity | 1 | 2012 | 153 | 0.100 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2014 | 587 | 0.100 |
Why?
|
| Phenotype | 2 | 2014 | 6502 | 0.100 |
Why?
|
| Flow Cytometry | 3 | 2016 | 3040 | 0.090 |
Why?
|
| Plasma Cells | 1 | 2012 | 196 | 0.090 |
Why?
|
| Poultry Diseases | 1 | 2010 | 13 | 0.090 |
Why?
|
| India | 2 | 2012 | 311 | 0.090 |
Why?
|
| Astrocytes | 1 | 2014 | 407 | 0.090 |
Why?
|
| Humans | 14 | 2024 | 270713 | 0.090 |
Why?
|
| Cochlea | 1 | 2011 | 116 | 0.090 |
Why?
|
| Metapneumovirus | 1 | 2010 | 57 | 0.090 |
Why?
|
| Neurons | 2 | 2012 | 2450 | 0.090 |
Why?
|
| Paramyxoviridae Infections | 1 | 2010 | 72 | 0.090 |
Why?
|
| Female | 11 | 2024 | 148885 | 0.090 |
Why?
|
| Immunophenotyping | 1 | 2014 | 1723 | 0.090 |
Why?
|
| Lymphocyte Activation | 1 | 2014 | 1719 | 0.080 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2011 | 155 | 0.080 |
Why?
|
| Disease Models, Animal | 4 | 2016 | 7317 | 0.080 |
Why?
|
| Macrophages | 2 | 2011 | 1334 | 0.080 |
Why?
|
| Viral Vaccines | 1 | 2010 | 301 | 0.080 |
Why?
|
| Mannose | 1 | 2008 | 44 | 0.080 |
Why?
|
| Virus Replication | 1 | 2011 | 762 | 0.070 |
Why?
|
| Urine | 1 | 2008 | 134 | 0.070 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2014 | 1095 | 0.070 |
Why?
|
| Brain Diseases | 1 | 2011 | 411 | 0.070 |
Why?
|
| Hepatitis C | 1 | 2012 | 548 | 0.070 |
Why?
|
| B7-H1 Antigen | 1 | 2014 | 1098 | 0.070 |
Why?
|
| Zoonoses | 1 | 2007 | 47 | 0.070 |
Why?
|
| Endemic Diseases | 1 | 2007 | 59 | 0.070 |
Why?
|
| Neutrophils | 1 | 2011 | 855 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2016 | 5657 | 0.070 |
Why?
|
| Pruritus | 1 | 2007 | 92 | 0.070 |
Why?
|
| Inflammation | 2 | 2013 | 2491 | 0.070 |
Why?
|
| Virulence Factors | 1 | 2008 | 231 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 2 | 2016 | 7052 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2011 | 1570 | 0.060 |
Why?
|
| Endocarditis, Bacterial | 1 | 2006 | 152 | 0.060 |
Why?
|
| Up-Regulation | 1 | 2011 | 2413 | 0.060 |
Why?
|
| Antibodies, Bacterial | 1 | 2007 | 402 | 0.060 |
Why?
|
| Exanthema | 1 | 2007 | 213 | 0.060 |
Why?
|
| Aged, 80 and over | 2 | 2024 | 31116 | 0.060 |
Why?
|
| Feces | 1 | 2008 | 851 | 0.060 |
Why?
|
| Epithelial Cells | 1 | 2011 | 1874 | 0.060 |
Why?
|
| Killer Cells, Natural | 1 | 2009 | 965 | 0.060 |
Why?
|
| Leukocytes | 2 | 2016 | 420 | 0.050 |
Why?
|
| 25-Hydroxyvitamin D 2 | 1 | 2022 | 7 | 0.050 |
Why?
|
| Calcifediol | 1 | 2022 | 17 | 0.050 |
Why?
|
| Middle Aged | 4 | 2024 | 90533 | 0.050 |
Why?
|
| Vitamins | 1 | 2022 | 149 | 0.050 |
Why?
|
| Rats | 1 | 2010 | 6397 | 0.050 |
Why?
|
| Nucleocapsid Proteins | 1 | 2020 | 11 | 0.050 |
Why?
|
| Chromatography, Liquid | 1 | 2022 | 352 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2020 | 3582 | 0.040 |
Why?
|
| Adult | 4 | 2024 | 82041 | 0.040 |
Why?
|
| Vitamin D | 1 | 2022 | 263 | 0.040 |
Why?
|
| Male | 5 | 2024 | 128479 | 0.040 |
Why?
|
| Cytomegalovirus | 2 | 2014 | 494 | 0.040 |
Why?
|
| Immunoglobulin M | 1 | 2020 | 350 | 0.040 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2020 | 165 | 0.040 |
Why?
|
| Biomarkers | 1 | 2011 | 5048 | 0.040 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 209 | 0.040 |
Why?
|
| Aged | 2 | 2024 | 73613 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2011 | 7232 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2020 | 39959 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2020 | 1101 | 0.030 |
Why?
|
| United States | 2 | 2024 | 15828 | 0.030 |
Why?
|
| Chemotaxis | 1 | 2016 | 135 | 0.030 |
Why?
|
| Neuroimmunomodulation | 1 | 2014 | 72 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2014 | 626 | 0.030 |
Why?
|
| Hepatitis C Antibodies | 1 | 2012 | 49 | 0.030 |
Why?
|
| HIV Antibodies | 1 | 2012 | 95 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2016 | 2315 | 0.020 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 2011 | 31 | 0.020 |
Why?
|
| Turkeys | 1 | 2010 | 7 | 0.020 |
Why?
|
| Mitogens | 1 | 2010 | 80 | 0.020 |
Why?
|
| Coinfection | 1 | 2012 | 198 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 2014 | 889 | 0.020 |
Why?
|
| Interleukin-18 | 1 | 2010 | 91 | 0.020 |
Why?
|
| Embryo, Nonmammalian | 1 | 2010 | 243 | 0.020 |
Why?
|
| Cell Survival | 1 | 2016 | 3057 | 0.020 |
Why?
|
| L-Selectin | 1 | 2009 | 35 | 0.020 |
Why?
|
| Chemokine CXCL10 | 1 | 2009 | 104 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2014 | 1824 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2011 | 1407 | 0.020 |
Why?
|
| Infant | 1 | 2024 | 13994 | 0.020 |
Why?
|
| Luciferases | 1 | 2009 | 454 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2009 | 398 | 0.020 |
Why?
|
| Child | 2 | 2024 | 30560 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2024 | 17072 | 0.020 |
Why?
|
| Cytokines | 1 | 2016 | 2803 | 0.020 |
Why?
|
| Spleen | 1 | 2009 | 718 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2016 | 6344 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2011 | 1273 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2011 | 1420 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2011 | 2986 | 0.020 |
Why?
|
| Young Adult | 1 | 2024 | 22243 | 0.020 |
Why?
|
| Adolescent | 1 | 2024 | 32689 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2009 | 4202 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 7648 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2014 | 12042 | 0.010 |
Why?
|